Clinical Trial Detail

NCT ID NCT04214392
Title Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of Recurrent or Progressive Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

malignant glioma

glioblastoma multiforme

Therapies

Chlorotoxin-CD28-CD3z-CD19t CART cells

Age Groups: adult senior

No variant requirements are available.